Top Video

Mylan CEO grilled on EpiPen profits

Wednesday, 21 Sep 2016 | 3:46 PM ET

Mylan CEO Heather Bresch's testifies the rising price of the EpiPen on Capitol Hill and discusses EpiPen profits and program costs.